Carvedilol Tablet, Film Coated
Product Images NDC 82009-128

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82009-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (634419aa D216 4ec3 A5fa 51a407da661d 01)

Chemical structure diagram showing the molecular formula of Carvedilol, a compound with multiple aromatic rings and hydroxyl functional groups, consistent with its identity as the active ingredient.*

FDA Label Image

Carvedilol Tablets (634419aa D216 4ec3 A5fa 51a407da661d 02)

A line graph comparing percentage mortality over 21 months between a placebo group and a Carvedilol group. The y-axis represents percent mortality, while the x-axis shows time in months. The Carvedilol group shows lower mortality rates than the placebo group throughout the observed period, with a P-value of 0.0014 indicating statistical significance.*

FDA Label Image

Carvedilol Tablets (634419aa D216 4ec3 A5fa 51a407da661d 03)

A forest plot graph depicting hazard ratios for multiple patient subgroups including men, women, age groups, racial groups, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, as well as for all patients combined. Each subgroup is represented by a point estimate and a confidence interval line extending horizontally along the hazard ratio scale from 0.0 to 2.0.*

FDA Label Image

Structured Formula For Carvedilol (634419aa D216 4ec3 A5fa 51a407da661d 04)

A line graph comparing mortality percentage over a 24-month period for two groups: one receiving Carvedilol and one receiving a placebo. The graph shows mortality increasing over time, with the Carvedilol group consistently having a lower mortality percentage than the placebo group. A p-value of 0.03 is noted, indicating statistical significance.*

FDA Label Image

Structured Formula For Carvedilol (634419aa D216 4ec3 A5fa 51a407da661d 05)

A forest plot chart depicting hazard ratios for various patient subgroups including age, gender, timing of randomization post-myocardial infarction, prior use of IV oral beta blockers, Killip class, thrombolytic therapy, PTCA use, presence of congestive heart failure, use of diuretics, angina status, hypertension, diabetes, heart rate categories, and systolic blood pressure levels. The chart visually compares risk estimates in these clinical categories.*

FDA Label Image

Carvedilol Tablets, 3.125 mg (634419aa D216 4ec3 A5fa 51a407da661d 06)

Carvedilol 3.125 mg film-coated tablets label from Quallent Pharmaceuticals Health LLC. The label states 500 tablets per container with the NDC 82009-125-05. It includes manufacturer details, dosage strength, and storage instructions.*

FDA Label Image

Carvedilol Tablets, 6.25 mg (634419aa D216 4ec3 A5fa 51a407da661d 07)

Label for Carvedilol Tablets, USP, 6.25 mg strength, oral film-coated tablets. The package contains 500 tablets. Labeled by Quallent Pharmaceuticals Health LLC. Includes NDC 82009-126-05, barcode, storage instructions, safety warnings, and manufacturing information from Zydus Lifesciences Ltd., India.*

FDA Label Image

Carvedilol Tablets, 12.5 mg (634419aa D216 4ec3 A5fa 51a407da661d 08)

Label for Carvedilol Tablets USP 12.5 mg film-coated tablets. The package contains 500 tablets and carries instructions for storage, safety, and dosing. It is manufactured by Zydus Lifesciences Ltd., India, for Quallent Pharmaceuticals Health LLC, Grand Cayman. The label includes a barcode and Rx only designation.*

FDA Label Image

Carvedilol Tablets,25 mg (634419aa D216 4ec3 A5fa 51a407da661d 09)

Carvedilol 25 mg film-coated tablets label showing the quantity of 500 tablets. The label displays the drug name, strength, and manufacturer information. It notes the product is prescription-only. The label includes storage instructions, safety warnings, and dosing references. The labeler is Quallent Pharmaceuticals Health LLC, with manufacturing by Zydus Lifesciences Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.